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Non-allergic rhinitis is a term used for situations where no allergen can be detected 
as the cause of rhinitis. In non-allergic rhinitis; Skin test positivity or specific Ig E 
response cannot be detected. The pathophysiology of nonallergic rhinitis (NAR) is 
heterogeneous. The most common type is vasomotor rhinitis, also called idiopathic. In 
addition, there are many types such as hormonal, gustatory, occupational, atrophic, 
cold air-induced and systemic diseases. Patients; They present with symptoms such 
as nasal congestion, runny nose, sneezing, and itching in the nose, the symptoms of 
the patients do not show a seasonal pattern. There are family stories, but they are not 
as common as allergic rhinitis (AR). An underlying factor such as infection, sinusitis 
or polyps cannot be detected in patients. It was determined that the patients showed 
more neurogenic abnormalities in the pathophysiology. These patients have been 
shown to be hypersensitive to substances with ingredients such as cold air or capsa-
icin. The diagnosis is made clinically, the onset of the disease is in adolescence. Oral/
nasal antihistamines, steroids, leukotriene antagonists are used in the treatment.
Keywords: non-allergic rhinitis, IgE, vasomotor rhinitis, eosinophilic nonallergic 
rhinitis, rhinitis medicomentosa
1. Non-allergic rhinitis
Non-allergic rhinitis is a term used for situations where no allergen can be 
detected as the cause of rhinitis. Non-allergic rhinitis occurs in approximately one 
third of allergic rhinitis. Affects 22 million people (7% of the population) in the USA 
[1]. In non-allergic rhinitis; Skin test positivity or specific Ig E response cannot be 
detected. The pathophysiology of nonallergic rhinitis (NAR) is heterogeneous. [2] 
The most common type is vasomotor rhinitis, also called idiopathic. In addition, 
there are many types such as hormonal, gustatory, occupational, atrophic, cold 
air-induced and systemic diseases [3]. Patients; They present with symptoms such 
as nasal congestion, runny nose, sneezing, and itching in the nose, the symptoms of 
the patients do not show a seasonal pattern. There are family stories, but they are not 
as common as allergic rhinitis (AR). An underlying factor such as infection, sinusitis 
or polyps cannot be detected in patients. It was determined that the patients showed 
more neurogenic abnormalities in the pathophysiology. These patients have been 
shown to be hypersensitive to substances with ingredients such as cold air or capsa-
icin. The diagnosis is made clinically, the onset of the disease is in adolescence [4].
2. Pathophysiology
Non-Allergic rhinitis occurs due to non-IgE mediated mechanisms. Prostaglandins, 
leukotrienes are found in both the upper and lower airways. These cause mast cell 
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secretion, eosinophils, after exposure to the allergen in rhinitis. Prostaglandins and 
leukotrienes released from mast cells cause vasodilatation and hypersecretion from 
the gland, leading to rhinitis symptoms. Although this mechanism is not fully active in 
non-allergic rhinitis, symptoms occur with a similar effect [5].
3. Vasomotor rhinitis
Vasomotor rhinitis; It constitutes the most important part of rhinitis in the 
definition of non-allergic rhinitis. Its other name is known as non-allergic rhinopa-
thy. It occurs as a result of impaired vasomotor balance in the nose. There is a loop 
in the form of sympathetic/parasympathetic innervation in the nose. This cycle is 
disrupted due to reasons such as exercise, cold, stress, insufficient thyroid functions, 
pregnancy, excessive or prolonged use of some blood pressure drugs, birth control 
pills and decongestant drugs. At the beginning of all these reasons, nasal congestion 
is temporary and reversible. So if the cause is removed, the disease will improve. In 
addition, if it lasts long enough, this time the blood vessels will lose their elasticity 
and the event turns into an irreversible situation. Metabolic (Acromegaly, Pregnancy, 
Hypothyroidism), Autoimmune (Sjogren’s syndrome SLE Relapsing polychondritis 
Churg-Straus),Granulomatous diseases (Sarcoidosis and Wegener’s granulomatosis), 
Other (Cystic fibrosis, Cilia dyskinesia syndromes, Immunodeficiency, Amyloidosis, 
Chronic fatigue syndrome) are the most common causes of NAR [6].
4. Gustatuar rhinitis
Typically, it starts after consuming hot or spicy food and alcohol. It starts with 
a food allergy or an unknown mechanism and continues with profuse rhinorrhea. 
Ipratropium bromide is used in the treatment [7].
5. Occupational rhinitis
Occupationally allergic and non-allergic can occur. There are four types. The 
first is an uncomfortable rhinitis without inflammation in the nose caused by smell. 
The second type is rhinitis that is caused by irritant and causes inflammation in the 
mucosa. The third type is corrosive rhinitis that occurs due to high concentration of 
chemicals in the nasal mucosa. Ammonia etc. occurs with inhalation of substances. 
The fourth type is rhinitis, which causes Ig E due to occupational exposure. Latex 
allergy in healthcare workers depends on this. Nasal saline irrigation solutions, nasal 
steroids and antihistamines are used in the treatment of this rhinitis [8] (Table 1).
6. Hormonal rhinitis
It is divided into two as gestational rhinitis induced by the menstrual cycle. 
Gestational rhinitis begins in the second trimester of pregnancy and continues 
until the second week of postpartum. It is related to pregnancy in another form of 
hormonal rhinitis. This can start in any week of pregnancy. Nasal saline irrigation 
is used in the treatment. In addition, they can benefit from the tapes used for the 
nose wings at night. The benefit of intranasal steroids in these patients has not been 
determined. The use of pseudoephedrine should be avoided during pregnancy, 




7. Rhinitis medicamentosa (drug-induced rhinitis)
It is a severe nasal congestion caused by the continuous use of agents such as 
oxymetazoline and phenylephrine, which are sympathomimetic agents. They use 
oral or topical steroids in treatment and sympathomimetic sprays are discontinued. 
Drugs such as ACE inhibitors, NSAIDs and Aspirin also have similar effects [10].
8. Atrophic rhinitis
Progressive nzal atrophy and Klebsiella ozaenae etc. It occurs due to mucosal 
colonization with microbial agents. There is a disturbing foul-smelling discharge 
on the jas. It can also develop after inferior turbinate surgery. Oral antibiotics, 
salty and oily washing solutions are used for malodorous discharge. Since the 
disease is very persistent, symptomatic patients should be followed up from time 
to time [11].
9. Non-allergic rhinitis with eosinophilia syndrome (NARES)
Known as non-allergic rhinitis with eosinophilic syndrome (NARES), the 
disease usually begins in adulthood; It is a type of non-allergic rhinitis characterized 
by negative skin test and normal IgE levels. Aspirin sensitivity, asthma and nasal 
polyps may develop in these patients. Eosinophilia is observed in patients. There 
is also an increased risk of obstructive sleep apnea syndrome. Another variant 
Drugs Usage areas Side effects
Antihistaminics Sneezing, runny nose, 
itchy nose
Anti-cholinergic side effects such as 
dryness of mucosal membranes, urinary 
retention, constipation, tachycardia, 
decreased visual acuity;






Nasal discharge, itching, 
sneezing
(Due to the systemic side 
effects of oral steroids, 
nasal steroids are in 
common use and are 
used as the first choice in 
treatment..
Besides growth retardation in children, 
metabolism disorders in all cases, 
glaucoma and cataract formation, 
immunosuppression, suppression of 




It is the gold standard 
in rhinitis that does 
not respond to 
antihistamines and nasal 
steroids.
Agitation aggression, anxiety, 
hallucination, depression, insomnia, 
irritability, restlessness, and suicidal 
thoughts.
Oral / Nasal decongestants
1. Pseudoephedrine and 
phenylephrine-oral
2. oxymetazoline, xylo-
metazoline and naphazoline 
(intranasal)
Nasal congestion When used orally, irritability, insomnia, 
irritability, headache, tachycardia, 
hypertension, increased intraocular 
pressure, urinary difficulty
Table 1. 
Drugs used in treatment [15].
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is Non-Allergic rhinitis disease with eosinophilia in the blood called BENARES. 
Although the clinic of the disease is the same as NARES; In this disease, there is 
eosinophilia in the blood instead of nasal eosinophilia. Intranasal corticosteroids are 
sufficient in both NARES and BENARES [12].
10. Infectious rhinitis
Infectious rhinitis is a type of rhinitis with acute or chronic runny nose, nasal 
congestion, frontal headache, smell disorders, post nasal discharge and cough. Most 
infectious rhinitis in children are viral and resolve with symptomatic treatment. If it 
is bacterial, antibiotics are used. In addition, nasal solutions, nasal steroids are also 
effective in treatment [13].
What are the risk factors?
• Exposure to smoke, exhaust fumes, or tobacco smoke
• Being over 20 years old. (Allergic rhinitis occurs before this age, non-allergic 
rhinitis occurs after the age of 20)
• Continuous use of decongestants: Nasal decongestants, which solve acute nasal 
congestion, cause congestion when used for a long time and increase congestion 
with rebaunt effect.
• Gender: Being a woman increases non-allergic rhinitis with hormonal effect.
• Occupation: Exposure to fumes from building materials, solvents or other 
chemicals
• Chronic diseases: such as hypothyroidism and chronic fatigue syndrome
• Stress. Emotional or physical stress increases susceptibility.
10.1 Complications
1. Nasal polyposis: Congestion and fluid increase in the sinuses trigger inflam-
mation. As a result, benign masses form and cause chronic obstruction in the 
nose.
2. Chronic Sinusitis: Congestion and fluid increase in the nasal area disrupt the 
nasal drainage and cause inflammation.
3. Middle ear infections: Congestion and increased fluid in the nasal area can 
obstruct the eustachian tube, leading to middle ear infections.
4. Disruption of daily activities: It can cause disruption of daily activities. It can 
lead to school failure or business difficulties in school children.
10.2 Diagnosis
In non-allergic rhinitis, the diagnosis is made by exclusion. First of all, allergic 
rhinitis is ruled out. Sinus problems are then ruled out. So there are no definitive 




1. Prick test: It is done to determine whether the symptoms are caused by an 
allergen. Allergens are applied to the skin and decided as positive or negative 
depending on the reaction.
2. Blood test: IgE levels are checked to measure immune response.
3. Nasal endoscopy: Pathologies such as nasal polyps and acute sinusitis are ruled 
out in endoscopy.
4. CT Imaging: Detailed imaging is performed for paranasal sinuses.
11. Treatment
Non-allergic rhinitis treatment is similar to allergic rhinitis. In treatment;
1. Avoiding causative factors: Cigarette smoke, perfume, spice or chemical 
odors should be avoided. Again, some drugs should be avoided. (Antihyper-
tensives, antidepressants, birth control drugs etc.)
2. Nasal irrigation: The use of saline nasal solutions provides both opening and 
moistening of the nose. In addition, oil-containing solutions cause further 
moistening of the nose and ensure the success of the treatment.
3. Pharmacotherapy: First of all, drug therapy should be tried. Treatment can 
be used with oral or nasal antihistamines, oral or nasal steroids, leukotriene 
antagonists [14].
• Antihistamines
Antihistamines are molecules that bind competitively to H1 receptors. They help 
us treat sneezing, runny nose and itchy nose by reducing the sensation of vascular 
permeability, smooth muscle contraction and itching.
Although first generation antihistamines are cheap, we know that there is 
serious central nervous system penetration. For this reason, unfortunately, almost 
10–40% of the patients cause severe distraction, sleepiness and concentration 
impairment. Anti-cholinergic side effects such as dryness in mucosal membranes, 
urinary retention, constipation, tachycardia, and decreased visual acuity limit the 
use of these drugs in elderly patients. In addition, the antagonistic effects of these 
drugs, which require long-term use, related to serotonin receptors, unfortunately, 
can cause weight gain. Trefenadine and astemizole are the first 2nd generation anti-
histamines and their central nervous system penetration is less than the old genera-
tion; However, they were removed from use in clinical practice due to arrhythmia 
caused by susceptible patients. Loratadine and cetirizine are generally less sedating 
new generation drugs. Levocetirizine is an enantiomer of the cetirizine molecule 
and unfortunately causes sedation at the effective doses. Fexofenadine, terfenadine; 
deslarotadine are also active metabolites of loratadine; these are sometimes referred 
to as 3rd generation antihistamines. It is reported that fexofenadine does not cross 
the blood brain barrier and therefore does not sedate. However, unfortunately, this 
is not the case in clinical use. Desloratadine is also reported to have more sedation 
and anti-cholinergic side effects [15].
Recently, anti-inflammatory effects of antihistamines have been mentioned. It is 
stated that mast cells and basophils stabilize the receptor independently by inhibit-
ing the transmembrane passage of calcium and intracellular cAMP, thus reducing 
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the release of inflammatory mediators such as histamine, tryptase and prostaglan-
din. However, many antihistamines are unfortunately unable to stabilize these cells 
at therapeutic doses. Ketotifen, olopatadine, azelastine, bepotastine and alkaftadine 
are mostly known as both H1 receptor antagonists and dual-acting antihistamines 
with mast cell stability. It is stated that some antihistamines inhibit NF-⁯B and 
GATA3 transcription via H1 receptor and thus achieve anti-inflammatory effect.
• Corticosteroids
Corticosteroids are the first-line anti-inflammatory drugs we know best for the 
treatment of many inflammatory diseases. Although corticosteroids have well-
known side effects, we see that they are still one of the most important pharma-
cological agents. In addition to growth retardation in children, side effects such as 
metabolism disorders, glaucoma and cataract formation, immunosuppression, sup-
pression of the HPA axis, thinning of the skin, behavioral disorders and osteoporosis 
are the most common ones in all cases. Due to these restrictions arising in systemic 
use, it is mostly used intranasally in AR. Among the intranasal preparations, they 
are currently the most used pharmacological products in primary care. Although 
the anti-inflammatory mechanisms of corticosteroids are not very clear, the most 
important effects are seen as cytokine and chemokine inhibition. They bind to gluco-
corticoid receptors (GR) in the cytoplasm, dimerize and pass into the nucleus; they 
then associate with the glucocorticoid response element (GRE) and consequently 
increase the transcription of the gene codes of anti-inflammatory proteins such as 
lipocortin-1, IL-10, IL-1 receptor antagonist and neutral endopeptidase.
Glucocorticoids also cause a considerable reduction in the number of inflam-
matory cells in nasal lavage fluid. Especially, they cause a significant decrease in 
eosinophil numbers. This is due to their inhibitory functions on both IL-5 and 
GM-CSF. Currently, beclamethasone monohydrate, budesonide, flunisolide, triam-
cinolone acetonide, fluticasone (propionate and furoate), mometasone furoate, and 
ciclesonide are commercially available nasal topical corticosteroids. There are no 
significant differences in clinical efficacy between these preparations.
Local burning and stinging sensation, irritation, dryness and sometimes nose-
bleeds can be encountered as topical side effects with these preparations [15].
• Leukotriene antagocytes
Leukotrienes are inflammatory lipid mediators synthesized from arachidonic 
acid that can be produced by mast cells, eosinophils, basophils and macrophages. 
The adventure of arachidonic acid cleavage that started with the posfolipase 
A2 enzyme from the nuclear membrane continues with leukotriene synthesis. 
Arachidonic acid is metabolized to LTA4 via the 5-lipoxygenase (5-LO) enzyme. 
LTC4, LTD4 and LTE4 are then formed through different convertases. We call these 
leukotrienes “cysteinyl leukotrienes (CsyLTs)”. CsyLTs has serious bronchial smooth 
muscle contraction, mucus production, edema and vascular permeability enhanc-
ing effects. LTD4 enhances the P-selectin pathway, increasing leukocyte adhesion 
and leukocyte aggregation to the inflammation site. It also plays an important role 
in eosinophil adhesion by increasing β2-integrins. As a result of nasal provocation 
with LD4 in normal humans, it was observed that nasal mucosal blood flow acceler-
ated and airway resistance increased.
Leukotrienes can be physiologically antagonized by blocking their synthesis or 
receptors. Zileuton is a 5-LO synthesis inhibitor and it is a pharmacological product 
that can block nasal congestion in patients with AR after allergen provocation. For 
now, only montelukast, which is a Cys LT1 receptor antagonist, has been approved 
for AR and is a commercial product. Montelukast is observed to improve congestion 




falling asleep, and sleeping at night. It is thought to reduce the number of peripheral 
eosinophils and thus create an anti-inflammatory effect. However, despite all these, 
there are many publications showing that it is much less effective than intranasal 
corticosteroids in terms of these effects. Although it looks like a safe preparation in 
general; Some psychiatric side effects such as agitation, aggression, anxiety, hal-
lucination, depression, insomnia, irritability, restlessness and suicidal thoughts are 
mentioned [15].
• Nasal decongestants
These drugs slow down nasal blood flow by antagonizing α1 and α2 adrenergic 
receptors in nasal capacitance vessel endothelium. In this way, they reduce nasal 
mucosal congestion and swelling. Better results can be obtained when combined 
with an antihistamine. Pseudoephedrine and phenylephrine, which are catechol-
amines, have oral forms. Although a runny nose can improve symptoms, it has no 
effect on itching, sneezing and eye symptoms in the nose. The imidazoline deriva-
tives oxymetazoline, xylometazoline and naphazoline are suitable for intranasal 
use. Although they are fast intranasal decongestants and have fewer side effects, 
severe rebound congestion effects occur when the drug is discontinued. In some 
publications, it is mentioned that oxymetazoline inhibits T cells and cytokines such 
as IL-1β, TNF-α, IL-6 and IL-8. Some local nasal side related to these preparations.
11.1 Monoclonal anti-IgE antibodies
Omaluzimab is a humanized, recombinant, monoclonal antibody that blocks the 
binding of circulating IgE antibodies to the high affinity receptors in cells such as 
mast cells and basophil by complexing with the Ce3 region. There are many publi-
cations showing that patients with AR provide a very serious clinical benefit by sig-
nificantly decreasing circulating IgE levels. In addition, it reduces FcR1 expressions 
on mast cells in both blood and tissue. It improves the nasal symptoms and increases 
the quality of life. It is an antibody that is well tolerated and has a very low risk of 
anaphylaxis (0.9/1000 applications). There are studies showing that SIT treatment 
applied together with omalizumab is more effective in single applications. The most 
important handicap is that it is currently an expensive treatment model. [15]
11.2 Capsaicin treatment, complementary and alternative medicine, surgery
Capsaicin is bound to vanilloid resertors expressed in nasal C-fibers. It has been 
observed that repeated applications to the skin or intranasally cause desensitization 
in the peripheral nerve endings. It works well in vasomotor rhinitis in which neu-
rotransmitters play an important role. It has been observed that it reduces symp-
toms such as nasal congestion, runny nose, and sneezing in AR. However, there are 
also publications showing that it has no clinical efficacy, especially in patients with 
house dust mite-sensitive PAR patients.
Nasal irrigation or irrigation with saline is a complementary treatment model 
in AR. In this form of treatment, it is ensured that the contact of the sinuses and 
pharynx with allergens and mucus is reduced. At the same time, edema in the nose 
is reduced. It has been shown that nasal saline application reduces the need for topi-
cal corticosteroids in children with AR.
It has been shown that exposure to microbes in children increases the expression 
of IL-10 and TGF-β inhibitory cytokines as well as the development of Th1-type 
immune response. There is evidence that beneficial microorganisms do this through 
toll-like respectors. Especially bifidobacteria and lactobacilli have such effects. 
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There is no sufficient and scientific evidence that acupuncture is effective in AR.
It has been stated that UV-A and UV-B are used, and that the patients are not 
able to use drugs or get sufficient response in a few small series. In only one study 
on AR, infrared radiation therapy (FIR) has been tried. It has been stated that the 
application of the oven affects the thermo-receptors due to the heat it emits and can 
be effective by increasing the microcirculation.
Surgical intervention may be beneficial for sinusitis, nasal polyps, enlarged turbi-
nates, or nasal septal deviation, if any, that do not respond to medical treatment. [15]
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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